Eisai
4523.T
#2011
Rank
S$10.56 B
Marketcap
$37.48
Share price
-0.53%
Change (1 day)
-41.61%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $2.96

According to Eisai's latest financial reports the company's current EPS (TTM) is $2.96. In 2022 the company made an earnings per share (EPS) of $2.17 a decrease over its 2021 EPS that were of $9.64.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.9636.3%
2022$2.17-77.48%
2021$9.64-41.88%
2020$16.59-0.94%
2019$16.7552.59%
2018$10.97124.17%
2017$4.90-49.42%
2016$9.6837.08%
2015$7.06-11.75%
2014$8.00-3.23%
2013$8.27-18.56%
2012$10.15-15.51%
2011$12.02-3.75%
2010$12.49-1.36%
2009$12.66